Task: Answer the multiple choice question.
Question: Which drug exhibits a 10.331\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
[a] CCC(CO)Oc1cc(NCc2ccccc2Cl)c2ncn(C(C)C)c2c1
[b] CCC(Oc1ccc(Br)cc1Cl)C(=O)Nc1nnc(C2CC2)s1
[c] O=C1NC(=Nc2ccccc2Cl)SC1(CO)CO
Answer: b. CCC(Oc1ccc(Br)cc1Cl)C(=O)Nc1nnc(C2CC2)s1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCC(Oc1ccc(Br)cc1Cl)C(=O)Nc1nnc(C2CC2)s1
CCC(Oc1ccc(Br)cc1Cl)C(=O)Nc1nnc(C2CC2)s1
2-(4-bromo-2-chlorophenoxy)-N-(5-cyclopropyl-1,3,4-thiadiazol-2-yl)butanamide